16th May 2005 15:30
Skyepharma PLC16 May 2005 For immediate release 16 May 2005 SKYEPHARMA TO PRESENT AT UBS 2005 GLOBAL PHARMACEUTICALS CONFERENCE LONDON, UK, 16 May 2005 -- SkyePharma PLC (Nasdaq: SKYE; LSE: SKP) announcestoday that the Company's Chief Executive Officer, Michael Ashton, will make apresentation at the UBS 2005 Global Pharmaceuticals Conference on Monday, May23rd, 2005 at 2.00 p.m. (Eastern Time) at the Grand Hyatt Hotel, New York. The presentation will be available via a live audio webcast and you are invitedto listen to the presentation by visiting www.ibb.ubs.com and clicking on theConferences icon in the middle right hand side of page and then follow the linkfor Webcast under the Global Pharmaceuticals Conference heading. For the slidesof this presentation, please go to SkyePharma's website www.skyepharma.com underthe Investor Relations tab. SkyePharma PLC develops pharmaceutical products benefiting from world-leadingdrug delivery technologies that provide easier-to-use and more effective drugformulations. There are now eleven approved products incorporating SkyePharma'stechnologies in the areas of oral, injectable, inhaled and topical delivery,supported by advanced solubilisation capabilities. For more information, visitwww.skyepharma.com. For further information please contact: SkyePharma PLC +44 207 491 1777Michael Ashton, Chief Executive OfficerPeter Laing, Director of Corporate Communications +44 205-491 5124Sandra Haughton, US Investor Relations +1 212 753 5780 Buchanan Communications +44 207 466 5000Tim Anderson / Mark Court This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
SKP.L